Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathogenetic factors in Sjögren's syndrome: recent developments.

T R Esch1

  • 1Department of Immunology, Forsyth Institute, Harvard School of Dental Medicine, Boston, MA 02115, USA. tesch@forsyth.org

Critical Reviews in Oral Biology and Medicine : an Official Publication of the American Association of Oral Biologists
|August 11, 2001
PubMed
Summary

This review explores Sjögren

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A novel lacrimal gland autoantigen in the NOD mouse model of Sjögren's syndrome.

Scandinavian journal of immunology·2002
Same author

Oligonucleotide containing CpG motifs enhances immune response to mucosally or systemically administered tetanus toxoid.

Vaccine·2001
Same author

Leukocytes infiltrating the submandibular glands of NOD mice express E-cadherin.

Journal of autoimmunity·2000
Same author

Transfer of human serum IgG to nonobese diabetic Igmu null mice reveals a role for autoantibodies in the loss of secretory function of exocrine tissues in Sjögren's syndrome.

Proceedings of the National Academy of Sciences of the United States of America·1998
Same author

Autoantibodies in salivary hypofunction in the NOD mouse.

Annals of the New York Academy of Sciences·1998
Same author

Neuritogenic Lewis rat T cells use Tcrb chains that include a new Tcrb-V8 family member.

Immunogenetics·1994

Area of Science:

  • Immunology
  • Pathogenesis
  • Autoimmune Diseases

Background:

  • Sjögren's syndrome (SS) pathogenesis research is limited by fragmented data integrating basic science and clinical observations.
  • The autoimmune nature of SS implicates T-cells, autoantibodies, and cytokines as key factors.
  • Programmed cell death (apoptosis) is emerging as a fourth potential disease mechanism in SS.

Purpose of the Study:

  • To review recent findings on the pathogenetic mechanisms of Sjögren's syndrome.
  • To emphasize the integration of basic research with clinical findings in SS.
  • To discuss four key areas: T-cell involvement, autoantibodies, cytokines, and apoptosis.

Main Methods:

  • Review of recent scientific literature on Sjögren's syndrome.
  • Emphasis on findings related to disease mechanisms.
  • Analysis of data concerning T-cell function, autoantibodies, cytokines, and apoptosis.

Main Results:

  • Confirmed antigen presentation to T-cells in salivary glands and the role of adhesion molecules.
  • New data on T-cell receptor repertoires and antigenic specificities.
  • Insights into autoantibody specificities potentially affecting exocrine function and cytokine production.

Conclusions:

  • Recent findings provide a more integrated understanding of SS pathogenesis.
  • Apoptosis research shows variable results, necessitating further investigation into influencing factors and resolving discrepancies.
  • Continued research into T-cells, autoantibodies, cytokines, and apoptosis is crucial for understanding and treating SS.

Related Experiment Videos